Breaking News Instant updates and real-time market news.

2020-03-17 09:55:47 09:55 03/17/20 03/17 09:55 03/17/20 09:55	Cowen Inc (Notes) [7.75% Senior Notes Due 2033] trading resumes

TODAY'S FREE FLY STORIES

Recommendations	3M price target lowered to $197 from $208 at Credit Suisse » 08:37 01/27/21 01/27 08:37 01/27/21 08:37 MMM 3M $175.97 / +5.41 (+3.17%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MMM 3M $175.97 / +5.41 (+3.17%) 01/25/21 Longview Acquisition Corp., Butterfly Network: Todd Fruchterman to become CEO 01/17/21 Fly Intel: Top five weekend stock stories 12/21/20 Apogee Enterprises names Ty Silberhorn as CEO 12/03/20 3M to take $250M-$300M in restructuring actions, 2,900 positions to be impacted MMM 3M $175.97 / +5.41 (+3.17%) 07:05 Today JPMorgan 3M upgraded to Overweight with shares 'cheap enough' at JPMorgan 06:29 Today Citi 3M price target raised to $188 from $185 at Citi 05:18 Today JPMorgan 3M upgraded to Overweight from Neutral at JPMorgan 01/13/21 Deutsche Bank 3M named 'Catalyst Call: Buy Idea' at Deutsche Bank MMM 3M $175.97 / +5.41 (+3.17%) 01/26/21 3M sees FY21 EPS $9.20-$9.70, consensus $9.52 01/26/21 3M reports Q4 adjusted EPS $2.38, consensus $2.15 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MMM 3M $175.97 / +5.41 (+3.17%) 01/16/21 3M stock 'unloved, underpriced,' Barron's says 09/22/20 3M exploring possible sale of food safety division, Bloomberg says 09/22/20 3M exploring possible sale of food safety division, Bloomberg says MMM 3M $175.97 / +5.41 (+3.17%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: Pre-market Movers MMM 3M $175.97 / +5.41 (+3.17%) 01/26/21 Unusually active option classes on open January 26th 08/05/20 3M call volume above normal and directionally bullish 07/28/20 Unusually active option classes on open July 28th
Hot Stocks	Vaxart announces publication on healh care economic findings » 08:36 01/27/21 01/27 08:36 01/27/21 08:36 VXRT Vaxart $9.39 / -0.67 (-6.66%) Vaxart announced health… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options VXRT Vaxart $9.39 / -0.67 (-6.66%) 01/26/21 Vaxart announces additional preclinical COVID-19 oral vaccine data 11/16/20 Vaxart hosting KOL panel call for investors 11/12/20 Vaxart announces additional data from Hamster Challenge study 10/14/20 Vaxart discloses receipt of grand jury subpoena, SEC document request VXRT Vaxart $9.39 / -0.67 (-6.66%) 11/18/20 B. Riley Securities Vaxart price target lowered to $16 from $22 at B. Riley Securities 10/13/20 B. Riley Securities B. Riley views Vaxart as key player in 'second wave' of Covid vaccines 09/09/20 B. Riley FBR Astra trial hold opens window for other vaccine candidates, says B. Riley FBR 08/12/20 H.C. Wainwright Vaxart price target raised to $17 from $7 at H.C. Wainwright VXRT Vaxart $9.39 / -0.67 (-6.66%) 11/12/20 Vaxart reports Q3 EPS (8c), consensus (9c) VXRT Vaxart $9.39 / -0.67 (-6.66%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 09/14/20 Fly Intel: Wall Street's top stories for Monday 09/14/20 Fly Intel: Wall Street's top stories at midday VXRT Vaxart $9.39 / -0.67 (-6.66%) 01/26/21 Unusually active option classes on open January 26th 01/08/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names 01/04/21 Largest borrow rate increases among liquid names
Initiation	Stamps.com assumed with a Buy at Maxim » 08:36 01/27/21 01/27 08:36 01/27/21 08:36 STMP Stamps.com $240.42 / +2.45 (+1.03%) Maxim analyst Allen Klee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events STMP Stamps.com $240.42 / +2.45 (+1.03%) 10/14/20 Stamps.com subsidiary ShipStation announces integration with Alibaba.com STMP Stamps.com $240.42 / +2.45 (+1.03%) 08/07/20 Northland Stamps.com downgraded to Market Perform from Outperform at Northland 08/07/20 Craig-Hallum Stamps.com price target raised to $340 from $300 at Craig-Hallum 08/03/20 Craig-Hallum Stamps.com price target raised to $300 from $230 at Craig-Hallum 05/28/20 Northland Northland keeps Outperform on Stamps.com, sees e-commerce volume to persist STMP Stamps.com $240.42 / +2.45 (+1.03%) 11/05/20 Stamps.com sees FY20 adjusted EPS $10.35-$11.35, consensus $8.10 11/05/20 Stamps.com reports Q3 adjusted EPS $3.83, consensus $1.53 08/06/20 Stamps.com raises FY20 adj. EPS view to $6.25-$9.25 from $4-$5 08/06/20 Stamps.com reports Q2 adjusted EPS $3.11, consensus $1.26 STMP Stamps.com $240.42 / +2.45 (+1.03%) 11/05/20 Fly Intel: After-Hours Movers 08/06/20 Fly Intel: After-Hours Movers 07/28/20 Goldman says buy Shopify as e-commerce shift accelerates growth 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	VF Corp. on track to return to growth in Q4 » 08:36 01/27/21 01/27 08:36 01/27/21 08:36 VFC VF Corp. $85.18 / +0.35 (+0.41%) Comments taken from Q3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options VFC VF Corp. $85.18 / +0.35 (+0.41%) 08:10 Today VF Corp. sees FY21 Dickies revenue up more than 7% on a reported basis 08:09 Today VF Corp. sees FY21 Timberland revenue down less than 19% on a reported basis 08:08 Today VF Corp. sees FY21 North Face revenue down less than 10% on a reported basis 08:08 Today VF Corp. sees FY21 Vans revenue down less than 15% on a reported basis VFC VF Corp. $85.18 / +0.35 (+0.41%) 01/25/21 Cowen VF Corp. price target raised to $99 from $91 at Cowen 01/25/21 Pivotal Research VF Corp. price target raised to $86 from $76 at Pivotal Research 01/22/21 Williams Capital VF Corp. initiated with a Buy at Williams Trading 01/21/21 Deutsche Bank VF Corp. upgraded to Buy from Hold at Deutsche Bank VFC VF Corp. $85.18 / +0.35 (+0.41%) 06:56 Today VF Corp. sees FY21 adjusted EPS approximately $1.30, consensus $1.36 06:55 Today VF Corp. reports Q3 adjusted EPS 93c, consensus 90c 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open VFC VF Corp. $85.18 / +0.35 (+0.41%) 11/03/20 McDonald's appoints Reginald Miller as new diversity chief, AP reports VFC VF Corp. $85.18 / +0.35 (+0.41%) 11/17/20 American initiation, Moderna downgrade among today's top calls on Wall Street 10/19/20 UnitedHealth downgrade, Tesla target raise among top calls on Wall Street 10/16/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 08:30 Today VF Corp. - VFC VFC VF Corp. $85.18 / +0.35 (+0.41%) 08/28/20 Unusually active option classes on open August 28th
Earnings	Progressive reports Q4 EPS $2.85, consensus $1.66 » 08:36 01/27/21 01/27 08:36 01/27/21 08:36 PGR Progressive $91.63 / -0.91 (-0.98%) Reports net premiums… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Options PGR Progressive $91.63 / -0.91 (-0.98%) 01/13/21 Gordon Haskett Allstate lowering auto rates by 5% in several states, says Gordon Haskett 01/08/21 Goldman Sachs Progressive downgraded to Sell from Neutral at Goldman Sachs 01/07/21 B. Riley Securities Progressive price target raised to $96 from $88 at B. Riley Securities 01/04/21 Wells Fargo Progressive downgraded to Underweight from Equal Weight at Wells Fargo PGR Progressive $91.63 / -0.91 (-0.98%) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 12/18/20 Progressive reports November EPS $1.26 vs. 52c last year 11/24/20 Progressive reports October EPS 40c vs. 52c last year PGR Progressive $91.63 / -0.91 (-0.98%) 09/22/20 Amazon upgrade, PayPal initiation among today's top calls on Wall Street PGR Progressive $91.63 / -0.91 (-0.98%) 12/07/20 Early notable gainers among liquid option names on December 7th

Hot Stocks	Canadian Pacific launches five-for-one share split, new share repurchase program » 08:36 01/27/21 01/27 08:36 01/27/21 08:36 CP Canadian Pacific $342.17 / -2.4 (-0.70%) Canadian Pacific will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CP Canadian Pacific $342.17 / -2.4 (-0.70%) 01/21/21 Cerner appoints Marck Erceg as CFO 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 CP Canadian Pacific $342.17 / -2.4 (-0.70%) 01/26/21 Raymond James Canadian Pacific upgraded at Raymond James on improved traffic outlook 01/26/21 Raymond James Canadian Pacific upgraded to Outperform from Market Perform at Raymond James 01/21/21 Scotiabank Canadian National, Canadian Pacific cut at Scotiabank on valuation (yesterday) 01/20/21 Scotiabank Canadian Pacific downgraded to Sector Perform from Outperform at Scotiabank CP Canadian Pacific $342.17 / -2.4 (-0.70%) 10/20/20 Canadian Pacific sees at least mid-single-digit adjusted EPS growth in 2020 10/20/20 Canadian Pacific reports Q3 adjusted EPS C$4.12 vs. C$4.61 last year 16:30 Today Canadian Pacific - CP
Recommendations	Texas Instruments price target raised to $200 from $170 at Credit Suisse » 08:35 01/27/21 01/27 08:35 01/27/21 08:35 TXN Texas Instruments $171.48 / -1.43 (-0.83%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TXN Texas Instruments $171.48 / -1.43 (-0.83%) 01/26/21 Texas Instruments sees 2021 annual operating tax rate ~14% 01/26/21 Texas Instruments CEO says Q4 revenue driven by strong demand in automotive 12/09/20 Texas Instruments: Most of HiRel semiconductor products now available online 11/18/20 Xilinx works with Texas Instruments to develop DFE radio application solutions TXN Texas Instruments $171.48 / -1.43 (-0.83%) 07:59 Today Jefferies Texas Instruments price target raised to $206 from $185 at Jefferies 07:27 Today RBC Capital Texas Instruments price target raised to $180 from $155 at RBC Capital 06:54 Today Deutsche Bank Texas Instruments price target raised to $170 from $150 at Deutsche Bank 06:43 Today Mizuho Texas Instruments price target raised to $175 from $162 at Mizuho TXN Texas Instruments $171.48 / -1.43 (-0.83%) 01/26/21 Texas Instruments sees Q1 EPS $1.44-$1.66 , consensus $1.34 01/26/21 Texas Instruments reports Q4 EPS $1.80, consensus $1.34 01/26/21 Notable companies reporting after market close 10/20/20 Texas Instruments sees Q4 EPS $1.20-$1.40, consensus $1.19 TXN Texas Instruments $171.48 / -1.43 (-0.83%) 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says 08/22/20 'Underappreciated' Synaptics shares have more upside, Barron's says 08/13/20 Intel unveils transistor technology to boost chip performance, Reuters says TXN Texas Instruments $171.48 / -1.43 (-0.83%) 01/26/21 Fly Intel: After-Hours Movers 10/20/20 Fly Intel: After-Hours Movers TXN Texas Instruments $171.48 / -1.43 (-0.83%) 01/26/21 Texas Instruments options imply 6.5% move in share price post-earnings 12/28/20 Texas Instruments put volume heavy and directionally bearish 12/21/20 Texas Instruments put volume heavy and directionally bearish 11/10/20 Texas Instruments put volume heavy and directionally bearish
Recommendations	Allstate unit sale transaction 'a clear positive,' says Evercore ISI » 08:35 01/27/21 01/27 08:35 01/27/21 08:35 ALL Allstate $109.54 / -1.4 (-1.26%) , BX Blackstone $65.07 / +0.035 (+0.05%) After Allstate (ALL)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ALL BX ALL Allstate $109.54 / -1.4 (-1.26%) 01/26/21 Allstate to sell Allstate Life Insurance Co. to Blackstone entities for $2.8B 01/26/21 Allstate to sell Allstate Life Insurance Co. to Blackstone entities for $2.8B 01/04/21 Allstate announces closing of $4B acquisition of National General 12/17/20 Allstate names Susan Lees chief sustainability officer BX Blackstone $65.07 / +0.035 (+0.05%) 01/26/21 Allstate to sell Allstate Life Insurance Co. to Blackstone entities for $2.8B 01/26/21 Allstate to sell Allstate Life Insurance Co. to Blackstone entities for $2.8B 01/24/21 Fly Intel: Top five weekend stock stories 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash ALL BX ALL Allstate $109.54 / -1.4 (-1.26%) 01/13/21 Gordon Haskett Allstate lowering auto rates by 5% in several states, says Gordon Haskett 11/17/20 Barclays Allstate initiated with an Overweight at Barclays 09/22/20 Keefe Bruyette Allstate upgraded to Outperform from Market Perform at Keefe Bruyette 07/22/20 Citi Citi opens 'Positive Catalyst Watch' on Allstate shares BX Blackstone $65.07 / +0.035 (+0.05%) 01/14/21 Fly Intel: Top five analyst initiations 01/14/21 Piper Sandler Blackstone initiated with an Overweight at Piper Sandler 10/29/20 Oppenheimer Blackstone upgraded to Outperform at Oppenheimer 10/29/20 Oppenheimer Blackstone upgraded to Outperform from Perform at Oppenheimer ALL BX ALL Allstate $109.54 / -1.4 (-1.26%) 11/04/20 Allstate reports Q3 adjusted EPS $2.94, consensus $1.66 11/04/20 Notable companies reporting after market close 08/04/20 Allstate reports Q2 adjusted EPS $2.46, consensus $1.55 08/04/20 Notable companies reporting after market close BX Blackstone $65.07 / +0.035 (+0.05%) 08:03 Today Blackstone reports Q4 distributable EPS $1.13, consensus 89c 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/29/20 Blackstone reported Q3 distributable EPS 63c, consensus 57c (yesterday) BX BX Blackstone $65.07 / +0.035 (+0.05%) 01/24/21 Foley-backed SPAC nears $7.3B deal with Blackstone's Alight, Reuters reports 01/12/21 Blackstone's Aadhar intends to file for IPO in India, Bloomberg says 01/07/21 Carlyle working with banks on rival bid for Signature Aviation, Sky News says 01/05/21 Oatly planning 2021 initial public offering, CNBC reports ALL BX ALL Allstate $109.54 / -1.4 (-1.26%) 11/04/20 Fly Intel: After-Hours Movers 10/01/20 Fly Intel: Wall Street's top stories for Thursday 10/01/20 Fly Intel: Wall Street's top stories at midday 09/22/20 Amazon upgrade, PayPal initiation among today's top calls on Wall Street BX Blackstone $65.07 / +0.035 (+0.05%) 01/03/21 Opening Day: Six IPOs to watch in 2021 11/20/20 Fly Intel: Wall Street's top stories at midday 09/10/20 Fly Intel: Wall Street's top stories for Thursday 09/10/20 Fly Intel: Wall Street's top stories at midday 02/24/21 22nd Annual Virtual Financial Services Forum 09:00 Today Blackstone - BX 02/04/21 Allstate - ALL BX BX Blackstone $65.07 / +0.035 (+0.05%) 12/15/20 Largest borrow rate increases among liquid names 12/09/20 Blackstone call volume above normal and directionally bullish 11/18/20 Blackstone trader unwinds massive election hedge after nearly a month 10/21/20 Unusual put flow in option market yesterday
Hot Stocks	Kaleyra and WebEngage announce new strategic partnership » 08:34 01/27/21 01/27 08:34 01/27/21 08:34 KLR Kaleyra $13.27 / -0.5 (-3.63%) Kaleyra announced a new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Options KLR Kaleyra $13.27 / -0.5 (-3.63%) 11/25/20 Kaleyra announce two new agreements with financial institutions from k-lab KLR Kaleyra $13.27 / -0.5 (-3.63%) 01/06/21 Northland Kaleyra named a top pick for 2021 at Northland 10/02/20 Northland Twilio comments positive for Kaleyra, LivePerson and Vonage, says Northland 07/28/20 National Securities Kaleyra initiated with a Buy at National Securities 06/29/20 Oppenheimer Kaleyra initiated with an Outperform at Oppenheimer 25 Jun KLR Kaleyra $13.27 / -0.5 (-3.63%) 09/16/20 Eight new option listings and one option delisting on September 16th
Hot Stocks	United Airlines expands COVID-19 testing, pre-clearance for Hawaii travel » 08:34 01/27/21 01/27 08:34 01/27/21 08:34 UAL United Airlines $41.25 / +0.87 (+2.15%) Beginning February 1,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options UAL United Airlines $41.25 / +0.87 (+2.15%) 01/21/21 United expects international profits to turn more quickly than domestic 01/21/21 United says EBITDA margins should exceed 2019 levels by 2023 01/20/21 United Airlines reports Q4 total passengers down 63.2% y/y 01/05/21 CEO says XpresSpa adding more airport, airlines on-site COVID test locations UAL United Airlines $41.25 / +0.87 (+2.15%) 01/14/21 Susquehanna United Airlines price target raised to $40 from $38 at Susquehanna 01/11/21 Cowen United Airlines upgraded to Outperform from Market Perform at Cowen 01/08/21 Fly Intel: Top five analyst downgrades 01/08/21 BofA United Airlines downgraded to Underperform from Neutral at BofA UAL United Airlines $41.25 / +0.87 (+2.15%) 01/20/21 United Airlines ended 2020 with $19.7B in available liquidity 01/20/21 United sees Q1 operating revenue down 65%-70%, consensus $4.06B 01/20/21 United Airlines reports Q4 adjusted EPS ($7.00), consensus ($6.60) 01/20/21 Notable companies reporting after market close 22 Apr UAL United Airlines $41.25 / +0.87 (+2.15%) 01/24/21 Biden to impose South Africa travel ban to combat COVID variant, Reuters says 01/22/21 United Airlines CEO wants to require staff get vaccinated for COVID, CNBC says 01/21/21 Biden to mandate int'l air travelers quarantine upon U.S. arrival, Reuters says 01/18/21 Biden to block Trump's plan to lift COVID travel restrictions, Reuters reports UAL United Airlines $41.25 / +0.87 (+2.15%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: Pre-market Movers UAL United Airlines $41.25 / +0.87 (+2.15%) 01/20/21 United Continental options imply 6.4% move in share price post-earnings 12/16/20 United Continental call volume above normal and directionally bullish 12/10/20 Unusual call flow in option market yesterday 12/09/20 Airlines put buyers prepare for turbulence

Hot Stocks	KemPharm announces FDA approval of IND for KP879 » 08:34 01/27/21 01/27 08:34 01/27/21 08:34 KMPH KemPharm $6.41 / -1.09 (-14.53%) KemPharm announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options KMPH KemPharm $6.41 / -1.09 (-14.53%) 01/14/21 KemPharm announces presentations on KP415, serdexmethylphenidate 12/23/20 KemPharm announces 1-for-16 reverse stock split 12/22/20 KemPharm files IND for KP879 for treatment of stimulant use disorder 11/18/20 KemPharm, Corium to host investor event on KP415 strategy KMPH KemPharm $6.41 / -1.09 (-14.53%) 01/25/21 Roth Capital KemPharm initiated with a Buy at Roth Capital 05/20/20 H.C. Wainwright KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright 03/02/21 PDUFA Date for KP415 KMPH KemPharm $6.41 / -1.09 (-14.53%) 01/21/21 Eighteen new option listings and one option delisting on January 21st 12/21/20 Four new option listings and fifteen option delistings on December 21st
Recommendations	D.R. Horton price target raised to $100 from $88 at Credit Suisse » 08:34 01/27/21 01/27 08:34 01/27/21 08:34 DHI D.R. Horton $77.73 / -1.32 (-1.67%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DHI D.R. Horton $77.73 / -1.32 (-1.67%) 01/26/21 D.R. Horton sees Q2 gross margin similar to Q1 01/26/21 D.R. Horton 'well-positioned' for spring selling season 01/26/21 D.R. Horton sees FY21 homes closed 80,000-82,000 homes 01/26/21 D.R. Horton reports ROE of 24.4% for trailing 12 months ended December 31 DHI D.R. Horton $77.73 / -1.32 (-1.67%) 01/21/21 Janney Montgomery Scott Meritage Homes initiated with a Neutral at Janney Montgomery Scott 01/21/21 Janney Montgomery Scott D.R. Horton initiated with a Neutral at Janney Montgomery Scott 01/08/21 RBC Capital D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital 01/08/21 RBC Capital D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital DHI D.R. Horton $77.73 / -1.32 (-1.67%) 01/26/21 D.R. Horton sees Q2 revenue $6B-$6.2B, consensus $5.09B 01/26/21 D.R. Horton raises FY21 revenue view to $25.2B-$25.8B from $24B-$25B 01/26/21 D.R. Horton sees FY21 consolidated revenue $25.2B-$25.8B, consensus $25.07B 01/26/21 D.R. Horton reports Q1 EPS $2.14, consensus $1.69 DHI D.R. Horton $77.73 / -1.32 (-1.67%) 08/29/20 Toll Brothers, Taylor Morrison could benefit from housing demand, Barron's says DHI D.R. Horton $77.73 / -1.32 (-1.67%) 01/26/21 Fly Intel: Pre-market Movers 01/08/21 Another Tesla upgrade among today's top calls on Wall Street 11/10/20 Fly Intel: Pre-market Movers DHI D.R. Horton $77.73 / -1.32 (-1.67%) 01/21/21 Early notable gainers among liquid option names on January 21st 01/13/21 Early notable gainers among liquid option names on January 13th 12/07/20 D R Horton call volume above normal and directionally bullish 11/10/20 Early notable gainers among liquid option names on November 10th
Hot Stocks	Microbot Medical completes discussions with FDA for Self-Cleaning Shunt » 08:33 01/27/21 01/27 08:33 01/27/21 08:33 MBOT Microbot Medical $9.08 / -0.02 (-0.22%) Microbot Medical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly MBOT Microbot Medical $9.08 / -0.02 (-0.22%) 01/21/21 Microbot Medical announces additions to Scientific Advisory Board 01/14/21 Microbot announces results of additional animal feasibility study with LIBERTY 11/17/20 Microbot Medical receives patents in multiple jursidictions 10/07/20 Microbot Medical receives notice of allowance for U.S. patent MBOT Microbot Medical $9.08 / -0.02 (-0.22%) 08/18/20 H.C. Wainwright Microbot Medical price target raised to $20 from $19 at H.C. Wainwright 05/01/20 H.C. Wainwright Microbot Medical price target lowered to $19 from $26 at H.C. Wainwright MBOT Microbot Medical $9.08 / -0.02 (-0.22%) 11/25/20 Fly Intel: After-Hours Movers
Recommendations	American Express price target lowered to $115 from $120 at Credit Suisse » 08:33 01/27/21 01/27 08:33 01/27/21 08:33 AXP American Express $116.14 / -5.05 (-4.17%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AXP American Express $116.14 / -5.05 (-4.17%) 01/26/21 American Express reports Q4 Global Merchant, Network Services net income $208M 01/26/21 American Express reports Q4 Global Commercial Services net income $538M 01/26/21 American Express reports Q4 Global Consumer Services Group net income $1.1B 01/15/21 American Express reports December write-off rate 1.6% vs. 1.9% month prior AXP American Express $116.14 / -5.05 (-4.17%) 08:19 Today Oppenheimer American Express price target lowered to $128 from $136 at Oppenheimer 01/19/21 Fly Intel: Top five analyst upgrades 01/19/21 JPMorgan American Express upgraded to Overweight from Underweight at JPMorgan 01/12/21 Susquehanna American Express price target raised to $124 from $110 at Susquehanna AXP American Express $116.14 / -5.05 (-4.17%) 01/26/21 American Express reports Q4 EPS $1.76, consensus $1.31 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Fly Intel: What to watch in credit card space earnings reports 01/25/21 Notable companies reporting before tomorrow's open AXP American Express $116.14 / -5.05 (-4.17%) 01/07/21 AmEx says no evidence found of misleading sales practice patterns 01/07/21 Treasury, Federal Reserve investigating AmEx sales tactics, WSJ reports 01/07/21 Federal investigators probing AmEx business-card sales practices, WSJ reports 08/14/20 An AmEx employee questioned sales practices than her career slid, WSJ reports AXP American Express $116.14 / -5.05 (-4.17%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Wall Street's top stories for Thursday AXP American Express $116.14 / -5.05 (-4.17%) 10/23/20 Unusually active option classes on open October 23rd 08/27/20 American Express call volume above normal and directionally bullish
Hot Stocks	Sanofi's priority is to continue to develop two Covid vaccine candidates » 08:32 01/27/21 01/27 08:32 01/27/21 08:32 SNY Sanofi $49.15 / -0.45 (-0.91%) , GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) , TBIO Translate Bio $23.13 / -1.5 (-6.09%) Sanofi (SNY) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SNY GSK TBIO SNY Sanofi $49.15 / -0.45 (-0.91%) 08:31 Today Sanofi to provide support to BioNTech in manufacturing Covid vaccine 01/25/21 Nanobiotix to partner with Sanofi on gene therapy pipeline 01/12/21 Sanofi says IPO on Euronext Paris for European API company evaluated for 2022 01/12/21 Sanofi, Biond Biologics enter global licensing agreement for BND-22 GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) 07:30 Today AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail 01/21/21 Immutep announces GlaxoSmithKline discontinuation of GSK2831781 trial TBIO Translate Bio $23.13 / -1.5 (-6.09%) 01/07/21 Translate Bio expects interim data from mRNA therapeutic trial in Q2 12/22/20 Translate Bio announces departure of CFO John Schroer 10/15/20 Sanofi, Translate Bio: COVID-19 vaccine candidate induced high antibody levels 10/07/20 Translate Bio announces upcoming presentations at NACFC SNY GSK TBIO SNY Sanofi $49.15 / -0.45 (-0.91%) 01/19/21 UBS Sanofi price target lowered to EUR 99 from EUR 100 at UBS 01/15/21 Deutsche Bank Sanofi initiated with a Sell at Deutsche Bank 01/08/21 Morgan Stanley Sanofi price target raised to EUR 105 from EUR 101 at Morgan Stanley 01/08/21 Morgan Stanley Roche downgraded to Equal Weight from Overweight at Morgan Stanley GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse TBIO Translate Bio $23.13 / -1.5 (-6.09%) 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 10/04/20 Goldman Sachs Translate Bio initiated with a Buy at Goldman Sachs 07/07/20 H.C. Wainwright Translate Bio price target raised to $32 from $18 at H.C. Wainwright 07/06/20 Fly Intel: Top five analyst initiations SNY GSK SNY Sanofi $49.15 / -0.45 (-0.91%) 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year 07/29/20 Sanofi reports Q2 business EPS EUR 1.28 vs. EUR 1.18 last year GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER 26 Jun SNY GSK TBIO SNY Sanofi $49.15 / -0.45 (-0.91%) 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says TBIO Translate Bio $23.13 / -1.5 (-6.09%) 08/28/20 Sanofi CEO more confident about COVID-19 vaccine candidates, Reuters says SNY GSK SNY Sanofi $49.15 / -0.45 (-0.91%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK 05/18/21 PDUFA Date for Avalglucosidase Alfa GSK GSK GlaxoSmithKline $39.24 / +0.33 (+0.85%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st

Hot Stocks	Abercrombie & Fitch appoints Holly May as Chief Human Resources Officer » 08:32 01/27/21 01/27 08:32 01/27/21 08:32 ANF Abercrombie & Fitch $24.39 / -0.04 (-0.16%) Abercrombie & Fitch… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ANF Abercrombie & Fitch $24.39 / -0.04 (-0.16%) 01/11/21 Abercrombie & Fitch CEO says 'our digital sales continue to be robust' 12/01/20 Hollister announces long-term partnership with The Academy Group 11/24/20 Abercrombie & Fitch announces early exit of four more flagships 10/27/20 Tapestry promotes Joanne Crevoiserat to CEO ANF Abercrombie & Fitch $24.39 / -0.04 (-0.16%) 01/14/21 JPMorgan Abercrombie & Fitch price target raised to $26 from $24 at JPMorgan 12/30/20 B. Riley Securities B. Riley checks show holiday outperformance for four retailers 12/01/20 Morgan Stanley Abercrombie & Fitch price target raised to $14 from $10 at Morgan Stanley 11/25/20 Baird Abercrombie & Fitch price target raised to $24 from $14 at Baird ANF Abercrombie & Fitch $24.39 / -0.04 (-0.16%) 01/11/21 Abercrombie & Fitch sees Q4 net sales down 5%-7%, consensus $1.12B 11/24/20 Abercrombie & Fitch reports Q3 adj. EPS 76c, consensus 0c 08/27/20 Abercrombie & Fitch not providing outlook for FY20 08/27/20 Abercrombie & Fitch sees Q3 net sales fown 15%-20% vs. last year. ANF Abercrombie & Fitch $24.39 / -0.04 (-0.16%) 08/27/20 Fly Intel: Pre-market Movers ANF Abercrombie & Fitch $24.39 / -0.04 (-0.16%) 11/30/20 Abercrombie & Fitch put volume heavy and directionally bearish 08/27/20 Unusually active option classes on open August 27th
Hot Stocks	Cellectar Biosciences receives orphan drug designation for CLR 131 » 08:31 01/27/21 01/27 08:31 01/27/21 08:31 CLRB Cellectar Biosciences $1.86 / -0.04 (-2.11%) Cellectar Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CLRB Cellectar Biosciences $1.86 / -0.04 (-2.11%) 01/12/21 Cellectar Biosciences initiates trial of CLR 131 11/05/20 Cellectar Biosciences announces publication of data on CLR 131 09/09/20 Cellectar Biosciences reports data on CLR 131 Phase 2 CLOVER-1 study 08/17/20 Cellectar presents poster on CLR 131 in relapsed or refractory LPL/WM CLRB Cellectar Biosciences $1.86 / -0.04 (-2.11%) 07/01/20 Oppenheimer Oppenheimer bullish on Cellectar Biosciences, initiates with an Outperform 07/01/20 Oppenheimer Cellectar Biosciences initiated with an Outperform at Oppenheimer 06/23/20 Fly Intel: Top five analyst initiations 06/23/20 Maxim Cellectar Biosciences initiated with a Buy at Maxim CLRB Cellectar Biosciences $1.86 / -0.04 (-2.11%) 11/09/20 Cellectar Biosciences reports Q3 EPS (15c), consensus (20c) 08/10/20 Cellectar Biosciences reports Q2 EPS (26c), consensus (30c) 23 Dec 02/25/21 Cellectar Biosciences, Inc. 02/25/21 Cellectar Biosciences, Inc.
Recommendations	Lockheed Martin price target lowered to $334 from $351 at Credit Suisse » 08:31 01/27/21 01/27 08:31 01/27/21 08:31 LMT Lockheed Martin $330.69 / -13.195 (-3.84%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events LMT Lockheed Martin $330.69 / -13.195 (-3.84%) 01/26/21 Lockheed Martin sees reducing office space by 2M square feet 01/26/21 Lockheed Martin sees ending 2021 with over $5B in cash 01/26/21 Lockheed Martin sees Biden administration bringing continuity to U.S. defense 01/26/21 Lockheed Martin sees companywide sales up 4% this year LMT Lockheed Martin $330.69 / -13.195 (-3.84%) 01/07/21 Baird Lockheed Martin downgraded to Neutral from Outperform at Baird 01/07/21 Jefferies Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely 12/22/20 Credit Suisse Lockheed Martin price target raised to $409 from $400 at Credit Suisse 12/22/20 Truist Aerojet Rocketdyne downgraded to Hold from Buy at Truist LMT Lockheed Martin $330.69 / -13.195 (-3.84%) 01/26/21 Lockheed Martin sees FY21 EPS $26.00-$26.30, consensus $26.11 01/26/21 Lockheed Martin reports Q4 EPS $6.38, consensus $6.41 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open LMT Lockheed Martin $330.69 / -13.195 (-3.84%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports 12/29/20 State Department approves sale of military helicopters to Kuwait, Reuters says 10/29/20 White House proceeds with sale of 50 F-35 planes to UAE, Reuters says 10/07/20 Quatar requests to purchase Lockheed Martin F-35 jets, Reuters reports LMT Lockheed Martin $330.69 / -13.195 (-3.84%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Pre-market Movers 01/02/21 Week in review: How Trump's policies moved stocks 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference
Hot Stocks	Sanofi to provide support to BioNTech in manufacturing Covid vaccine » 08:31 01/27/21 01/27 08:31 01/27/21 08:31 SNY Sanofi $49.15 / -0.45 (-0.91%) , BNTX BioNTech $106.18 / -4.355 (-3.94%) , PFE Pfizer $37.31 / +0.025 (+0.07%) Sanofi (SNY) and BioNTech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SNY BNTX PFE SNY Sanofi $49.15 / -0.45 (-0.91%) 01/25/21 Nanobiotix to partner with Sanofi on gene therapy pipeline 01/12/21 Sanofi says IPO on Euronext Paris for European API company evaluated for 2022 01/12/21 Sanofi, Biond Biologics enter global licensing agreement for BND-22 01/11/21 Philip Morris appoints Jorge Insuasty as chief life sciences officer BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/25/21 BioNTech, Shanghai Fosun receive Hong Kong approval for Covid vaccine 01/22/21 Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine PFE Pfizer $37.31 / +0.025 (+0.07%) 06:47 Today Pfizer: Xeljanz study in RA did not meet co-primary endpoints 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/26/21 Myovant Sciences, Pfizer report 'positive' results from Phase 3 SPIRIT study 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil SNY BNTX PFE SNY Sanofi $49.15 / -0.45 (-0.91%) 01/19/21 UBS Sanofi price target lowered to EUR 99 from EUR 100 at UBS 01/15/21 Deutsche Bank Sanofi initiated with a Sell at Deutsche Bank 01/08/21 Morgan Stanley Sanofi price target raised to EUR 105 from EUR 101 at Morgan Stanley 01/08/21 Morgan Stanley Roche downgraded to Equal Weight from Overweight at Morgan Stanley BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE Pfizer $37.31 / +0.025 (+0.07%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg SNY BNTX PFE SNY Sanofi $49.15 / -0.45 (-0.91%) 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year 07/29/20 Sanofi reports Q2 business EPS EUR 1.28 vs. EUR 1.18 last year BNTX BioNTech $106.18 / -4.355 (-3.94%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate PFE Pfizer $37.31 / +0.025 (+0.07%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 23 Jul 06 Feb SNY BNTX PFE SNY Sanofi $49.15 / -0.45 (-0.91%) 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/26/21 Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says PFE Pfizer $37.31 / +0.025 (+0.07%) 01/26/21 Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports 01/25/21 Italy issues warning letter to Pfizer due to COVID vaccine delays, Reuters says 01/25/21 Pfizer to ship fewer vaccine vials to fulfill commitment to U.S., NY Times says 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports SNY BNTX PFE SNY Sanofi $49.15 / -0.45 (-0.91%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday PFE Pfizer $37.31 / +0.025 (+0.07%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 05/18/21 PDUFA Date for Avalglucosidase Alfa 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 BNTX PFE BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th PFE Pfizer $37.31 / +0.025 (+0.07%) 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th
Hot Stocks	Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B » 08:30 01/27/21 01/27 08:30 01/27/21 08:30 PRSP Perspecta $26.23 / -0.3 (-1.13%) Perspecta announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events PRSP Perspecta $26.23 / -0.3 (-1.13%) 08:28 Today Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B 08:23 Today Perspecta trading halted, news pending 01/13/21 Perspecta unit awarded prime contract from DoD worth up to $6.2M 01/06/21 Perspecta holder Veritas reports 11.7% active stake, seeks transaction talks PRSP Perspecta $26.23 / -0.3 (-1.13%) 06/12/20 William Blair William Blair sees near-term takeover of Perspecta as unlikely despite Jana news 04/02/20 Wells Fargo Perspecta price target lowered to $18.50 from $26 at Wells Fargo 03/30/20 William Blair Perspecta initiated with a Market Perform at William Blair 03/25/20 Wells Fargo Good news for government contractors in COVID -19 bill, says Wells Fargo PRSP Perspecta $26.23 / -0.3 (-1.13%) 11/10/20 Perspecta raises FY21 adj. EPS view to $2.03-$2.11 from $1.90-$2.03 11/10/20 Perspecta reports Q2 adjusted EPS 53c, consensus 50c 08/06/20 Perspecta backs FY21 adjusted EPS view $1.90-$2.03, consensus $1.95 08/06/20 Perspecta reports Q1 adjusted EPS 47c, consensus 45c PRSP Perspecta $26.23 / -0.3 (-1.13%) 12/10/20 Perspecta working with Goldman to weigh options, Dealreporter says 11/09/20 Perspecta said to weigh strategic options, Bloomberg says 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference

Options	Two new option listings and one option delisting on January 27th » 08:30 01/27/21 01/27 08:30 01/27/21 08:30 JAGX Jaguar Health $3.27 / -0.06 (-1.80%) , EIDX acquired by BBIO $122.42 / + (+0.00%) New option listings for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly JAGX EIDX JAGX Jaguar Health $3.27 / -0.06 (-1.80%) 01/22/21 Jaguar Health regains compliance with Nasdaq 12/23/20 Jaguar Health in $6M financing transaction involving royalty rights 12/07/20 Nasdaq listing panel to evaluate time period give to Jaguar on minimum bid rule 12/04/20 Jaguar Health enters fifth amendment to accounts receivable agreement with Oasis EIDX acquired by BBIO $122.42 / + (+0.00%) 01/26/21 BridgeBio completes acquisition of Eidos Therapeutics 01/19/21 BridgeBio and Eidos' stockholders approve acquisition 01/04/21 ISS recommends BridgeBio, Eidos shareholders vote for proposed merger 12/11/20 Eidos jumps after filing shows rival takeover interest over $120 per share JAGX EIDX JAGX Jaguar Health $3.27 / -0.06 (-1.80%) EIDX acquired by BBIO $122.42 / + (+0.00%) 12/30/20 Citi Eidos Therapeutics price target raised to $129 from $73.26 at Citi 11/18/20 BTIG Eidos Therapeutics downgraded to Neutral from Buy at BTIG 10/12/20 H.C. Wainwright BridgeBio price target raised to $53 from $50 at H.C. Wainwright 10/07/20 Fly Intel: Top five analyst downgrades EIDX EIDX acquired by BBIO $122.42 / + (+0.00%) 10/29/20 Eidos Therapeutics reports Q3 EPS (79c), consensus (71c) EIDX EIDX acquired by BBIO $122.42 / + (+0.00%) 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says 12/11/20 GlaxoSmithKline said to bid $120 per share for Eidos, Bloomberg reports EIDX EIDX acquired by BBIO $122.42 / + (+0.00%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Fly Intel: Pre-market Movers
Recommendations	Johnson & Johnson price target raised to $193 from $168 at Credit Suisse » 08:29 01/27/21 01/27 08:29 01/27/21 08:29 JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) 01/26/21 Johnson & Johnson says 'comfortable' meeting COVID-19 vaccine demand 01/26/21 Johnson & Johnson sees no biosimilar entrants in Pharmaceutical segment in FY21 01/26/21 Johnson & Johnson sees FY21 adjusted pre-tax operating margin up ~200 bps 01/26/21 Johnson & Johnson says Phase 3 COVID-19 vaccine study results due next week JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) 07:59 Today Cantor Fitzgerald Johnson & Johnson price target raised to $200 from $180 at Cantor Fitzgerald 07:51 Today Wells Fargo Johnson & Johnson price target raised to $190 from $175 at Wells Fargo 07:44 Today Raymond James Johnson & Johnson price target raised to $183 from $158 at Raymond James 07:42 Today Cowen Johnson & Johnson price target raised to $195 from $170 at Cowen JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Pre-market Movers 01/14/21 Fly Intel: Wall Street's top stories for Thursday 03/01/21 41st Annual Healthcare Virtual Conference JNJ Johnson & Johnson $170.48 / +4.47 (+2.69%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd
Upgrade	Prologis upgraded to Outperform following 'strong' Q4 at Evercore ISI » 08:29 01/27/21 01/27 08:29 01/27/21 08:29 PLD Prologis $106.11 / +3.1 (+3.01%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PLD Prologis $106.11 / +3.1 (+3.01%) 01/20/21 Prologis: Nippon Prologis REIT to issue new investment units PLD Prologis $106.11 / +3.1 (+3.01%) 05:51 Today Evercore ISI Prologis upgraded to Outperform from In Line at Evercore ISI 01/13/21 Jefferies First Industrial Realty upgraded to Buy with $49 price target at Jefferies 11/30/20 BTIG Prologis price target raised to $117 from $100 at BTIG 11/23/20 KeyBanc Prologis downgraded to Sector Weight at KeyBanc PLD Prologis $106.11 / +3.1 (+3.01%) 01/26/21 Prologis sees FY21 core FFO $3.88-$3.98, consensus $3.83 01/26/21 Prologis reports Q4 Core FFO 95c, consensus 92c 10/20/20 Prologis raises FY20 core FFO view to $3.76-$3.78 from $3.70 to $3.75 10/20/20 Prologis reports Q3 Core FFO 92c, consensus 88c
Hot Stocks	Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B 08:28 01/27/21 01/27 08:28 01/27/21 08:28 PRSP Perspecta $26.23 / -0.3 (-1.13%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events PRSP Perspecta $26.23 / -0.3 (-1.13%) 08:23 Today Perspecta trading halted, news pending 01/13/21 Perspecta unit awarded prime contract from DoD worth up to $6.2M 01/06/21 Perspecta holder Veritas reports 11.7% active stake, seeks transaction talks 12/17/20 Perspecta awarded $797.34M Navy contract modification PRSP Perspecta $26.23 / -0.3 (-1.13%) 06/12/20 William Blair William Blair sees near-term takeover of Perspecta as unlikely despite Jana news 04/02/20 Wells Fargo Perspecta price target lowered to $18.50 from $26 at Wells Fargo 03/30/20 William Blair Perspecta initiated with a Market Perform at William Blair 03/25/20 Wells Fargo Good news for government contractors in COVID -19 bill, says Wells Fargo PRSP Perspecta $26.23 / -0.3 (-1.13%) 11/10/20 Perspecta raises FY21 adj. EPS view to $2.03-$2.11 from $1.90-$2.03 11/10/20 Perspecta reports Q2 adjusted EPS 53c, consensus 50c 08/06/20 Perspecta backs FY21 adjusted EPS view $1.90-$2.03, consensus $1.95 08/06/20 Perspecta reports Q1 adjusted EPS 47c, consensus 45c PRSP Perspecta $26.23 / -0.3 (-1.13%) 12/10/20 Perspecta working with Goldman to weigh options, Dealreporter says 11/09/20 Perspecta said to weigh strategic options, Bloomberg says 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference
Earnings	Norwood Financial reports Q4 earnings 67c vs. 57c last year » 08:27 01/27/21 01/27 08:27 01/27/21 08:27 NWFL Norwood Financial $25.31 / +0.23 (+0.92%) Total assets were $1.852B… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly NWFL Norwood Financial $25.31 / +0.23 (+0.92%) 12/10/20 Norwood Financial raises cash dividend 4% to 26c per share NWFL Norwood Financial $25.31 / +0.23 (+0.92%) 10/23/20 Norwood Financial reports Q3 EPS 62c vs. 62c last year NWFL Norwood Financial $25.31 / +0.23 (+0.92%) 12/28/20 Fly Insider:180 Degree Capital, AMC among week's notable insider trades

Events

Earnings calls, analyst events, roadshows and more

NSC
Today at 08:45

Norfolk Southern - NSC Conference Calls
GD
Today at 09:00

General Dynamics - GD Conference Calls
OSK
Today at 09:00

Oshkosh - OSK Conference Calls
EHC
Today at 09:00

Encompass Health - EHC Conference Calls
FCNCA
Today at 09:00

First Citizens - FCNCA Conference Calls
ABT
Today at 09:00

Abbott - ABT Conference Calls
GIB
Today at 09:00

CGI Inc. - GIB Conference Calls
BX
Today at 09:00

Blackstone - BX Conference Calls
RES
Today at 09:00

RPC, Inc. - RES Conference Calls
KMI
Today at 09:00

Kinder Morgan, Inc. Firm Sponsored Meetings

, Houston, TX

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SCPS X SCPS Scopus BioPharma IPO Managers: Benchmark, Joseph Gunnar Priced at: $9.00 1M Shares SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer Priced at: $25.00 77M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TIRX X TIRX Tian Ruixiang IPO Managers: Network 1 Financial Priced at: $4.00 3M Shares GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James Priced at: $5.75 8.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities Priced at: $14.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley Priced at: $65.00 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen Priced at: $38.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum Priced at: $6.75 3.225M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	No deals
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Cowen Inc (Notes) [7.75% Senior Notes Due 2033] trading resumes

TODAY'S FREE FLY STORIES

Get Full Fly Access